Novartis Pharma AG - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for PRECISION BIOSCIENCES INC (DTIL)

Filing Manager: NOVARTIS PHARMA AG
Reporting Manager: Novartis Pharma AG
Security: PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share
Symbol: DTIL
Shares outstanding: 7.66M shares
Disclosed Ownership: 414K shares
Ownership: 5.4%
Form type: SCHEDULE 13G/A
Date filed: 2/12/2025, 05:00 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Novartis Pharma AG	5.4%	414K	0	414K	/s/ Christian Rehm	Christian Rehm
Novartis AG	5.4%	414K	0	414K	/s/ Christian Rehm	Christian Rehm